The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Antiviral Activity and Mechanism of Action of Ganciclovir
Abstract
Ganciclovir (9-[(1,3-dihydroxy-2-propoxy)methyl]guanine) is a potent inhibitor of viruses of the herpes family, including cytomegalovirus (CMV), that are pathogenic for humans and animals. The primary mechanism of ganciclovir action against CMV is inhibition of the replication of viral DNA by ganciclovir-5'-triphosphate (ganciclovir-TP). This inhibition includes a selective and potent inhibition of the viral DNA polymerase. Ganciclovir is metabolized to the triphosphate form by primarily three cellular enzymes: (1) a deoxyguanosine kinase induced by CMV-infected cells; (2) guanylate kinase; and (3) phosphoglycerate kinase. Other nucleotide-metabolizing enzymes may be involved as well. The selective antiviral response associated with ganciclovir treatment is achieved because of the much weaker inhibition of cellular DNA polymerases by ganciclovir-TP. Activity and selectivity are also amplified by the accumulation of ganciclovir-TP in CMV-infected cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
9-(1,3-Dihydroxy-2-propoxymethyl)guanine: a new potent and selective antiherpes agent
Martin, J. C., Dvorak, C. A., Smee, D. F., Matthews, T. R., & Verheyden, J. P. H. (1983) · Journal of Medicinal Chemistry · doi:10.1021/jm00359a023 · Cited by 341
Self-citationAnti-herpesvirus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine
Smee, D. F., Martin, J. C., Verheyden, J. P., & Matthews, T. R. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.23.5.676 · Cited by 265
Self-citationCheng, Y. C., Huang, E. S., Lin, J. C., Mar, E. C., Pagano, J. S., Dutschman, G. E., & Grill, S. P. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.9.2767 · Cited by 253
Biron, K. K., Stanat, S. C., Sorrell, J. B., Fyfe, J. A., Keller, P. M., Lambe, C. U., & Nelson, D. J. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.8.2473 · Cited by 236
Acyclovir and Epstein--Barr virus infection
Pagano, J. S., Sixbey, J. W., & Lin, J.-C. (1983) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/12.suppl_b.113 · Cited by 118
Cited by
Update on Human Herpesvirus 6 Biology, Clinical Features, and Therapy
De Bolle, L., Naesens, L., & De Clercq, E. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.1.217-245.2005 · Cited by 529
Faulds, D., & Heel, R. C. (1990) · Drugs · doi:10.2165/00003495-199039040-00008 · Cited by 400
A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation
Merigan, T. C., Renlund, D. G., Keay, S., Bristow, M. R., Starnes, V., O'Connell, J. B., Resta, S., Dunn, D., Gamberg, P., Ratkovec, R. M., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204303261803 · Cited by 376
Next generation chimeric antigen receptor T cells: safety strategies to overcome toxicity
Yu, S., Yi, M., Qin, S., & Wu, K. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1057-4 · Cited by 264
Mathur, V., Burai, R., Vest, R. T., Bonanno, L. N., Lehallier, B., Zardeneta, M. E., Mistry, K. N., Do, D., Marsh, S. E., Abud, E. M., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.11.032 · Cited by 175
Metadata
- Authors
- Matthews, T., & Boehme, R.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1988-07-01
- Volume
- 10
- Issue
- Supplement_3
- Pages
- S490-S494
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2169058303
- Cited by
- 364
- References
- 5
- FWCI
- 9.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antiviral Activity and Mechanism of Action of Ganciclovir. https://app.cochat.ai/papers/10.1093/clinids/10.supplement_3.s490
- The paper
- Matthews, T., & Boehme, R. (1988). Antiviral Activity and Mechanism of Action of Ganciclovir. Clinical Infectious Diseases. https://doi.org/10.1093/clinids/10.supplement_3.s490
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.